News about Manufacturing

Agno Pharma Acquires Actylis's CDMO Manufacturing Asset

Agno Pharma Acquires Actylis's CDMO Manufacturing Asset

Agno Pharma has acquired Actylis’s CDMO manufacturing asset, the legacy Cascade Chemistry business based in Eugene, Oregon, strengthening Agno’s U. cGMP API development and manufacturing capabilities.

Manufacturing | 19/01/2026 | By News Bureau 191

Serum Institute to Produce 100,000 Doses of Oxford Rift Valley Fever Vaccine

Serum Institute to Produce 100,000 Doses of Oxford Rift Valley Fever Vaccine

Serum Institute of India will produce up to 100,000 doses of an investigational Rift Valley fever vaccine developed by the University of Oxford, as the viral disease continues to affect parts of West Africa. The doses may be used for testing and future outbreak response, under an agreement supported by CEPI.

Manufacturing | 17/01/2026 | By News Bureau 128

WuXi Biologics Introduces PatroLab to Enable Real-Time, Predictive Biomanufacturing

WuXi Biologics Introduces PatroLab to Enable Real-Time, Predictive Biomanufacturing

WuXi Biologics, a global contract research, development and manufacturing organization (CRDMO), has launched PatroLab, a next-generation digital twin platform aimed at reshaping bioprocess development and biologics manufacturing.

Manufacturing | 14/01/2026 | By Darshana 445

AbbVie Secures Global Manufacturing and Commercialization Rights to RemeGen's Bispecific Cancer Antibody

AbbVie Secures Global Manufacturing and Commercialization Rights to RemeGen's Bispecific Cancer Antibody

AbbVie and RemeGen, a China-based innovative biopharmaceutical company, have entered into an exclusive licensing agreement covering the development, manufacturing, and commercialization of RC148, a novel investigational PD-1/VEGF-targeted bispecific antibody for the treatment of advanced solid tumours.

Manufacturing | 13/01/2026 | By Darshana 157

Aragen Introduces CHOMax for Rapid IND-Enabling Clinical Supply

Aragen Introduces CHOMax for Rapid IND-Enabling Clinical Supply

Aragen has launched CHOMax, a fully integrated and royalty-free platform designed to accelerate the journey from DNA to IND-enabling clinical supply in approximately 10 months, combining cell line development, process and analytical development and GMP manufacturing with demonstrated high-performance outcomes.

Manufacturing | 13/01/2026 | By News Bureau 157

Novartis to Add Fourth US Radioligand Therapy Plant in Florida

Novartis to Add Fourth US Radioligand Therapy Plant in Florida

Novartis will expand its US radioligand therapy manufacturing network with a new purpose-built facility in Winter Park, Florida, strengthening patient access across the southeastern US and supporting the company’s broader USD 23 billion investment in advanced manufacturing and oncology innovation.

Manufacturing | 12/01/2026 | By News Bureau 229

Sharp Sterile Manufacturing Expands Capacity Via USD 28 Million Investment

Sharp Sterile Manufacturing Expands Capacity Via USD 28 Million Investment

With the new investment, Sharp Sterile Manufacturing aims to scale up throughput by adding an automated isolated filling line to support faster batch production.

Manufacturing | 08/01/2026 | By News Bureau 166

Intelligent Bio Solutions Ties Up With Syrma Johari MedTech to Scale Drug-Screening Device Manufacturing

Intelligent Bio Solutions Ties Up With Syrma Johari MedTech to Scale Drug-Screening Device Manufacturing

Intelligent Bio Solutions Inc (INBS), a medical technology company focused on rapid, non-invasive testing solutions, has entered into a strategic manufacturing partnership with Syrma Johari MedTech Ltd to scale production of its Intelligent Fingerprinting Drug Screening Reader and support long-term margin expansion.

Manufacturing | 03/01/2026 | By Darshana 197

A New Year, A New Chapter for Pharma Manufacturing in India

A New Year, A New Chapter for Pharma Manufacturing in India

As India steps into a new year, the pharmaceutical manufacturing sector stands at a defining crossroads. Over the past few years, Indian pharma has moved far beyond its traditional identity as the “pharmacy of the world” for generics.

Manufacturing | 01/01/2026 | By Darshana 205

Corona Remedies to Expand Bhayla Manufacturing Capacity by 400 Million Units

Corona Remedies to Expand Bhayla Manufacturing Capacity by 400 Million Units

Corona Remedies Limited has announced an expansion of manufacturing capacity at its Bhayla formulation facility to support rising demand for its products. The expansion will add 400 million units of tablet and capsule capacity, with 240 million units expected to be available for utilisation.

Manufacturing | 29/12/2025 | By Darshana 159

 
 

 

 

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

 pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members